Pharma Focus Asia

Eurofins Invests US$169 million to Expand the Chemistry Site in Spain

Introduction:
Eurofins with an investment of US$169 million plans for expansion of the chemistry site for the synthesis of chemicals and purification of drugs. The new manufacturing facility will be located in Murcia, Spain.

Features:
The state-of-the-art facility will be designed with a huge area covering 63,000 square. The new facility will double the size of existing capacity by expanding the current chemistry services capacity for drug discovery and thus enabling the synthesis and chemical purification of drugs initially.

The design principles of the new site make use of modern and functional design in optimising sample and supply flows within laboratories. New site will also offer chemistry capacity and capabilities by enabling new, associated services.

The completion of the project is expected to start its operations in early 2021.

NameEurofins
Type   Expansion
BudgetUS$169 million
Year2021

 

magazine-slider-imageMFA + MMA 2024CPHI Chine || PMEC China 2024Asia Healthcare Week 2024Advance DoE WorkshopNitrosamine Advance Workshop 2024CPHI Korea 2024CHEMICAL INDONESIA 2024INALAB 2024 Thermo Scientific - DynaDrive and DynaSpinDigital Health Asia 2024Rehab Expo 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals ConferencePharma Quality Excellence Awards 20244th Annual Pharma GMP Quality Management 20243rd World ADC Asia 2024LogiPharma Asia 2024